The Cyclic IMS P20 mass spectrometer combines multipass ion mobility, enhanced fragmentation, and molecular imaging to reveal subtle disease-related molecular changes.
Explore how dual binding assays reveal interactions between bispecific antibodies and their targets, providing insights into binding behavior and antibody function.